Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_676934efd5d32d690f8843a8645b2b72 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 |
filingDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9282569634f03dca49c607b105646e20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_479fb93ee801dc54e11b670f393c7d46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6280cf2e902b6a6fe9f7294208851b17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bfc5c2cab5044b2b006be52ea30b572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6b2e89644d16cfa0541d27045ea68d6 |
publicationDate |
2020-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3630806-A1 |
titleOfInvention |
Long-acting gip peptide analogues |
abstract |
Disclosed are glucose-dependent insulinotropic peptide (GIP)-derived peptide analogues GIP5-30 and GIP3-30 which are antagonists of the GIP receptor and comprises at least one fatty acid molecule to increase half-life while maintaining antagonistic properties. |
priorityDate |
2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |